Skip to content

Clinical trials

Phase 2 Hemophilia A trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hemophilia A Phase: Phase 2 Country / region: United States Clear all

19 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20051
20061
20071
20081
20091
20103
20151
20174
20183
20232

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed11
Terminated7
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Pfizer4
ApcinteX Ltd2
Novo Nordisk A/S2
Bayer1
CSL Behring1
Carelon Research1
Craig Seaman1
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico1
Grifols Therapeutics LLC1
National Institute of Allergy and Infectious Diseases (NIAID)1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hemophilia A19
Hemophilia B6
HIV Infections1
Hemorrhage1
Hepatitis C1
von Willebrand Diseases1

Trials

Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.